Chip Up

Chip Up

Share this article

  • Chipmaker Nvidia was recently present again at the J.P. Morgan Healthcare Conference. Nvidia is looking to tap into the growing tech and healthcare overlap and sees it as a billion-dollar-a-year business market. It is specifically focusing on the AI space with hopes of penetrating software-defined medical devices. Kimberley Powell, Vice President of Healthcare at Nvidia explained that “we recognize that healthcare is becoming the absolute largest data-generating industry and we have global challenges increasing the cost of healthcare delivery and access to healthcare. So we build computing platforms to serve these grand challenges”.

  • Powell went on to add how Nvidia chips are serving the healthcare market with applications in genomic discovery and AI all becoming prominent. One area was the brand tie-up with InstaDeep, which BioNTech has just acquired. The link-up saw the two feed AI models genetic data: the Gs, Ts, As, Cs and more that eventually get translated into our proteins. Using the DNA of hundreds of people, as well as Cambridge-1, the most powerful supercomputer in the U.K., the researchers found it was feasible to develop a generalizable program—a “genomic language model”.

Why it matters

Nvidia has a number of initiatives in the healthcare space. In 2021, the company announced that it had teamed up with pharma company AstraZeneca and the University of Florida on an AI for drug discovery and patient care initiative. Nvidia has also joined forces with Harvard University on an AI-based tool kit to help researchers gain access and insights about DNA. During the COVID-19 pandemic, the company released an automated speech recognition and natural language processing technology that can transcribe and organize information from a telemedicine visit for patients and clinicians.


Get Smarter
About Investing

Join 35,000+ subscribers and get our 5 min daily newsletter on daily local and international financial news.
Get Smarter<br/> About Investing

Similar News